Seattle biotech company Blaze Bioscience has received Fast Track designation from the FDA for a clinical program evaluating tozuleristide. Update, April 8: Blaze confirmed that it recently raised an additional $5 million, after… Read More
Editor’s note: The GeekWire Awards are now virtual on July 23. Watch live below. Technology is increasingly influencing the science of health, and the delivery of health care. Scientists and… Read More
Blaze Bioscience, a Seattle-based biotech company that’s using a protein borrowed from scorpion venom to make cancerous tumors glow, has passed its first clinical trial with flying colors and is… Read More
Seattle biotech company Blaze Bioscience has raised $5 million in funding as it pursues a pivotal trial for its “Tumor Paint,” a molecule that binds to cancer cells and lights them… Read More